Delivery Order SPE2DE24DA017-SPE2D626F9858
- Not listed
- This delivery order, valued at $2,548.39, was awarded to Arthrex Inc. on November 4, 2025, under a fixed-price contract with economic price adjustment provisions. The order supports the Defense Logistics Agency's Medical Supply Chain and is scheduled for completion by November 7, 2025, with performance at Arthrex's headquarters in Naples, Florida. No set-aside designation was used in this procurement, reflecting the contractor's competitive position in federal orthopedic device procurement. This...
- This delivery order, valued at $1,419.00 and awarded on November 5, 2025, represents a task order under Arthrex Inc.'s existing Indefinite Delivery Contract (IDC) SPE2DE24D0020 with the Defense Logistics Agency's Medical Supply Chain. The contract, which runs through September 1, 2029, with a total ceiling value of $471 million, authorizes procurement of orthopedic surgical products and technologies supporting Department of Veterans Affairs and Department of Defense healthcare facilities...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, received a delivery order award valued at $18,192.47 from the Defense Logistics Agency's Medical Supply Chain on August 18, 2025. The delivery order, classified as fixed price with economic price adjustment, is for implant system secondary fixation bioswivel components measuring 4.75x19.1 and is scheduled for completion by August 21, 2025. This award was made without a set-aside designation,...
- Arthrex Inc., a leading developer and manufacturer of minimally invasive orthopedic medical technologies, received a delivery order valued at $3,025.44 from the Defense Logistics Agency's Medical Supply Chain on September 16, 2025. This fixed-price delivery order with economic price adjustment is scheduled for completion by September 19, 2025, and will be performed at the company's headquarters in Naples, Florida. The award utilized no set-aside designation, reflecting Arthrex's strong...
- Arthrex Inc., a leading developer and supplier of minimally invasive orthopedic medical technologies based in Naples, Florida, has been awarded a delivery order valued at $1,155.96 by the Defense Logistics Agency's Medical Supply Chain on August 15, 2025. This fixed-price delivery order with economic price adjustment provisions represents a task order under Arthrex's larger Indefinite Delivery Contract (SPE2DE24D0020), a $471 million agreement running through September 2029 that enables Veterans...
- This delivery order, valued at $3,131.04, was awarded on August 21, 2025, to Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies. The order is issued under the Defense Logistics Agency's Medical Supply Chain, a defense-oriented federal agency, with a completion deadline of August 26, 2025. The contract utilizes fixed-price pricing with economic price adjustment terms and carries no set-aside designation, reflecting Arthrex's competitive standing...
- This delivery order, valued at $3,952.31, was awarded to Arthrex Inc. on October 30, 2025, by the Defense Logistics Agency's Medical Supply Chain, with an ultimate completion date of November 4, 2025. The contract employs fixed-price pricing with economic price adjustment and was issued without a set-aside designation, reflecting Arthrex's competitive position in federal procurement. The work will be performed in Naples, Florida, where Arthrex maintains its headquarters as a leading global...
- Arthrex Inc., a leading provider of minimally invasive orthopedic medical technologies headquartered in Naples, Florida, received a delivery order valued at $15,472.98 from the Defense Logistics Agency's Medical Supply Chain on September 17, 2025. The delivery order, classified as fixed price with economic price adjustment, calls for the implementation of a distal biceps repair delivery system and is scheduled for completion by September 22, 2025. This award was made without a set-aside...
- This delivery order, valued at $7,628.38, was awarded to Arthrex Inc. on September 3, 2025, for the supply of orthopedic medical technologies under the Defense Logistics Agency's Medical Supply Chain program. The order is classified as a fixed-price delivery with economic price adjustment provisions and is scheduled for completion by September 8, 2025. Arthrex, a global leader in minimally invasive orthopedic medical devices headquartered in Naples, Florida, will fulfill this order with...
- Arthrex Inc., a Naples, Florida-based orthopedic medical device manufacturer, received a delivery order valued at $23,591.04 from the Defense Logistics Agency's Medical Supply Chain on July 22, 2025. The order, which is due for completion by July 25, 2025, covers cannulated, quarter-square impact handles for orthopedic surgical applications. This delivery order represents a continuation of work under Arthrex's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency, valued at...
- SPE2DE24DA017Indefinite Delivery Contract
- SPE2DE24DA017-SPE2D626F9858Delivery Order
This delivery order, valued at $18,827.68 with a fixed-price economic price adjustment structure, was awarded to Arthrex Inc. on November 5, 2025, by the Defense Logistics Agency's Medical Supply Chain, a division of the Department of Defense. The order is expected to be completed by November 10, 2025, and will be performed at Arthrex's headquarters location in Naples, Florida. This award represents a task order under Arthrex's existing single-award Indefinite Delivery Contract (SPE2DE24D0020) valued at $471.05 million and effective through September 1, 2029, which authorizes the procurement of a comprehensive range of orthopedic products and surgical technologies supporting Department of Veterans Affairs medical centers and Department of Defense healthcare facilities nationwide. No set-aside designation was applied to this delivery order, reflecting Arthrex's competitive position as the established prime contractor under the master IDC vehicle. Arthrex specializes in minimally invasive orthopedic medical technologies, including surgical instruments, implants, and biologics such as joint replacement systems, suture anchors, bone screws, and advanced biologic products like ALLOSYNC DBM Putty and BIOCARTILAGE. The contractor serves as a direct supplier with no identified subcontractors, fulfilling orthopedic healthcare requirements across multiple surgical specialties for military personnel and veterans through streamlined task order issuance that eliminates the need for competitive re-evaluation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.8k | 11/5/25 |